- $5.94bn
- $5.51bn
- $461.12m
- 85
- 25
- 70
- 62
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K/A | 10-K/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 228 | 246 | 328 | 455 | 461 |
Cost of Revenue | |||||
Gross Profit | 176 | 186 | 258 | 347 | 358 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 328 | 290 | 304 | 472 | 308 |
Operating Profit | -100 | -44.1 | 24.3 | -17.3 | 153 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -82.5 | -36.5 | 23.3 | -7.83 | 187 |
Provision for Income Taxes | |||||
Net Income After Taxes | -86 | -40.5 | 18.3 | -14.3 | 334 |
Net Income Before Extraordinary Items | |||||
Net Income | -86 | -40.5 | 18.3 | -14.3 | 334 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -86 | -40.5 | 18.3 | -14.3 | 334 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.68 | -0.334 | 0.177 | 0.439 | 2.62 |